Cover Image
市場調查報告書

藥物輸送技術市場預測 ∼2020年:各投藥途徑 (口服、經肺、注射、眼、鼻子、局部、植入、粘膜等)

Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal (Oral)), Patient Care Setting - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 344812
出版日期 內容資訊 英文 254 Pages
訂單完成後即時交付
價格
Back to Top
藥物輸送技術市場預測 ∼2020年:各投藥途徑 (口服、經肺、注射、眼、鼻子、局部、植入、粘膜等) Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal (Oral)), Patient Care Setting - Global Forecast to 2021
出版日期: 2017年01月12日 內容資訊: 英文 254 Pages
簡介

藥物輸送技術的市場預計從2015年到2020年以7.5%的年複合成長率發展、從2015年的1兆481億美元、到2020年成長到1兆5047億美元的規模。慢性疾病的發病率上升和生物製藥市場成長、革新、技術的進步等要素,促進該市場成長。

本報告提供全球藥物輸送技術的市場相關調查,市場定義和概要,投藥途徑及劑型種類與概要,對市場成長的各種影響因素及市場機會分析,各投藥途徑、劑型、終端用戶、地區的市場趨勢與市場規模的變化與預測,競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 局部的藥物輸送技術的市場
  • 各終端用戶市場
  • 固態口服藥物輸送技術的市場
  • 各給藥途徑市場
  • 地區概要

第5章 市場概要

  • 簡介
  • 市場區隔
    • 各給藥途徑
    • 各用途
    • 各地區
  • 市場動態
    • 推進因素
    • 阻礙要素
    • 市場機會
    • 課題

第6章 市場分析:各給藥途徑

  • 簡介
  • 口服給藥
    • 固態
      • 平板電腦
      • 膠囊
      • 撲粉
      • 藥丸
    • 液體
      • 溶劑
      • 糖漿
    • 半固態
      • 凝膠
      • 乳膠
      • 酏劑
  • 肺部藥物輸送
    • 計量吸入
    • 乾粉吸入
    • 噴霧器
      • 噴氣式噴霧器
      • 超音波
      • 軟霧噴霧器
  • 注射
    • 注射器
      • 傳統注射器
      • 各材料
        • 玻璃
        • 塑膠
      • 各產品
        • 可填充注射器
        • 已填充注射器
      • 各可用性
        • 可重複使用
        • 拋棄式
      • 自行注射器
      • 無針注射器
      • 自動注射器
      • 筆型注射器
      • 穿戴式注射器
      • 其他
    • 注射用製劑
      • 傳統製劑
      • 新型製劑
      • 長時間作用性製劑
  • 眼部投藥
    • 液體
      • 點眼藥劑
      • 液體噴霧
    • 半固態
      • 凝膠
      • 眼軟膏劑
    • 接眼設備
      • 藥物塗膜隱形眼鏡
      • 眼球植入
  • 鼻腔藥物輸送
    • 點鼻子劑
    • 噴霧
    • 撲粉
    • 凝膠
  • 局部的藥物輸送
    • 液體
      • 溶劑
      • 懸浮劑
    • 半固態
      • 凝膠
      • 軟膏
    • 固態
      • 塞劑
    • 經皮藥物輸送
      • 貼片
      • 凝膠
  • 植入藥物輸送
    • 積極型
    • 被動型
  • 粘膜藥物輸送
    • 口服經粘膜
      • 口含
      • 舌下
    • 其他
      • 經肛門
      • 陰道粘膜

第7章 市場分析:各終端用戶

  • 簡介
  • 醫院
  • 居家護理
  • 門診外科醫療設施、診所
  • 診斷中心
  • 其他

第8章 市場分析:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
  • 亞洲
  • 其他

第9章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢
    • 新產品的認證、投入
    • 聯盟、協定、合作
    • 收購
    • 擴張

第10章 企業簡介

  • 簡介
  • BAYER AG
  • JOHNSON & JOHNSON SERVICES, INC.
  • NOVARTIS AG
  • PFIZER, INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • 3M COMPANY
  • ANTARES PHARMA, INC.
  • GLAXOSMITHKLINE PLC
  • MERCK & CO., INC.
  • SANOFI
    • 概要
    • 財務趨勢
    • 產品與服務
    • 主要策略
    • 近幾年的發展趨勢等

第11章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 3871

The drug delivery technology market is projected to reach USD 1,669.40 billion by 2021 from USD 1,179.20 billion in 2016, at a CAGR of 7.2% during the forecast period.

Increasing prevalence of chronic diseases, increasing demand for biologics, technological advancements, and new product launches are the factors driving the growth of this market. Whereas, self-administration & home care and rising demand for biosimilars and generic drugs offer significant growth opportunities for players operating in this market. On the other hand, risk of needle-stick injuries and side effects of drugs may restraint the growth of the market.

The drug delivery technology market is segmented based on route of administration, facility of use, and region. On the basis of route of administration, the market is segmented into oral, injectable, topical, nasal, ocular, pulmonary, implantable, and transmucosal. In 2016, the oral drug delivery segment is expected to account for the largest share of the market. This can be attributed to the wide range of benefits associated with oral drugs. The oral route of administration is one of the simplest, most convenient, and safest routes.

On the basis of facility of use, the market is segmented into the hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers, and other facilities of use. In 2016, the hospitals segment is expected to account for the largest share of the market. This can be primarily attributed to advantages such as the significant number of inpatient and outpatient visits in hospitals as compared to other end users and the requirement of large volumes of drugs and their respective delivery devices to cater to the demand of this patient pool.

Asia is expected to be fastest-growing region in the drug delivery technology market from 2016 to 2021. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities. In addition, the region has low costs of labor and clinical trials, which has further served to draw market players to Asia.

Prominent players in the drug delivery technology market include Johnson & Johnson, Inc. (U.S.), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Pfizer, Inc. (U.S.), Novartis AG (Switzerland), 3M Company (U.S.), Becton, Dickinson and Company (U.S.), GlaxoSmithKline plc, (U.K.), Sanofi (France), and Antares Pharma, Inc. (U.S.).

Research Coverage:

The report defines, describes, and forecast the drug delivery technology market on the basis of route of administration, facility of use, and region. It provides detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, challenges). The study tracks and analyzes competitive developments such as joint ventures, mergers and acquisitions, new product developments, and expansions in the drug delivery technology market across to four main regions, namely, North America, Asia, Europe, and RoW.

Reasons to Buy the Report:

The report on the drug delivery technology market provides quantitative information for clients seeking market size information on various segments of this market. This report also provides access to the quantitative data on the drug delivery technology market. This report covers -

  • Current and forecast assessment of the drug delivery technology market.
  • Country-wise assessment of each of the segments
  • Global market share analysis for major segments of the drug delivery technology market
  • Adoption trends of various drug delivery technologies for major geographic markets
  • Five-year coverage of strategic developments of top players in the drug delivery technology market
  • Product Portfolio mapping of leading players in the drug delivery technology market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. KEY DATA FROM SECONDARY SOURCES
  • 2.4. KEY DATA FROM PRIMARY SOURCES
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. TOPICAL DRUG DELIVERY: MARKET OVERVIEW
  • 4.2. DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE
  • 4.3. SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM
  • 4.4. DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION
  • 4.5. GEOGRAPHICAL SNAPSHOT OF THE DRUG DELIVERY TECHNOLOGY MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
  • 5.3. DRIVERS
    • 5.3.1. RISING PREVALENCE OF CHRONIC DISEASES
    • 5.3.2. GROWTH IN THE BIOLOGICS MARKET
    • 5.3.3. TECHNOLOGICAL ADVANCEMENT AND NEW PRODUCT LAUNCHES
  • 5.4. RESTRAINTS
    • 5.4.1. RISK OF NEEDLESTICK INJURIES AND SIDE EFFECTS OF DRUGS
    • 5.4.2. PRODUCT RECALLS
  • 5.5. OPPORTUNITIES
    • 5.5.1. SELF-ADMINISTRATION AND HOME CARE
    • 5.5.2. RISING DEMAND FOR BIOSIMILARS AND GENERIC DRUGS
      • 5.5.2.1. Biosimilars
      • 5.5.2.2. Generic drugs
    • 5.5.3. FOCUS ON OVERCOMING UNMET MEDICAL NEEDS
    • 5.5.4. EMERGING MARKETS
  • 5.6. CHALLENGES
    • 5.6.1. PATENT EXPIRY AND PATENT CLIFF
    • 5.6.2. PRICING PRESSURE

6. REGULATORY SCENARIO

  • 6.1. INTRODUCTION
  • 6.2. DRUG APPROVAL IN THE U.S.
  • 6.3. DRUG APPROVAL IN EUROPE

7. DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION

  • 7.1. INTRODUCTION
  • 7.2. ORAL DRUG DELIVERY
    • 7.2.1. SOLID ORAL DRUGS
      • 7.2.1.1. Tablets
      • 7.2.1.2. Capsules
      • 7.2.1.3. Powders
      • 7.2.1.4. Pills
    • 7.2.2. LIQUID ORAL DRUGS
      • 7.2.2.1. Solutions
      • 7.2.2.2. Syrups
    • 7.2.3. SEMI-SOLID ORAL DRUGS
      • 7.2.3.1. Gels
      • 7.2.3.2. Emulsions
      • 7.2.3.3. Elixirs
  • 7.3. PULMONARY DRUG DELIVERY
    • 7.3.1. FORMULATIONS
    • 7.3.2. DEVICES
      • 7.3.2.1. Metered Dose Inhalers
      • 7.3.2.2. Dry Powder Inhalers
      • 7.3.2.3. Nebulizers
        • 7.3.2.3.1. Jet nebulizers
        • 7.3.2.3.2. Ultrasonic nebulizers
        • 7.3.2.3.3. Soft mist nebulizers
  • 7.4. INJECTABLE DRUG DELIVERY
    • 7.4.1. DEVICES
      • 7.4.1.1. Conventional Injection Devices
        • 7.4.1.1.1. By material
        • 7.4.1.1.2. Glass
        • 7.4.1.1.3. Plastic
        • 7.4.1.1.4. By product
        • 7.4.1.1.4.1. Fillable syringes
        • 7.4.1.1.4.2. Prefilled syringes
        • 7.4.1.1.5. By usability
        • 7.4.1.1.5.1. Reusable syringes
        • 7.4.1.1.5.2. Disposable syringes
      • 7.4.1.2. Self-injection devices
        • 7.4.1.2.1. Needle-free injectors
        • 7.4.1.2.2. Autoinjectors
        • 7.4.1.2.3. Pen injectors
        • 7.4.1.2.4. Wearable injectors
      • 7.4.1.3. Other Injector Devices
    • 7.4.2. FORMULATIONS
      • 7.4.2.1. Conventional drug delivery
      • 7.4.2.2. Novel drug delivery formulations
      • 7.4.2.3. Long-acting injection formulations
  • 7.5. OCULAR DRUG DELIVERY
    • 7.5.1. FORMULATIONS
      • 7.5.1.1. Liquid Formulations
        • 7.5.1.1.1. Eye Drops
        • 7.5.1.1.2. Liquid Sprays
      • 7.5.1.2. Semi-solid Formulations
        • 7.5.1.2.1. Gels
        • 7.5.1.2.2. Eye Ointments
    • 7.5.2. OCULAR DEVICES
      • 7.5.2.1. Drug-coated Contact Lenses
      • 7.5.2.2. Ocular Inserts
  • 7.6. NASAL DRUG DELIVERY
    • 7.6.1. NASAL DROPS
    • 7.6.2. NASAL SPRAYS
    • 7.6.3. NASAL POWDERS
    • 7.6.4. NASAL GELS
  • 7.7. TOPICAL DRUG DELIVERY
    • 7.7.1. FORMULATIONS
      • 7.7.1.1. Liquid Topical Drug Delivery
        • 7.7.1.1.1. Solutions
        • 7.7.1.1.2. Suspensions
      • 7.7.1.2. Semi-solid topical drug delivery
        • 7.7.1.2.1. Creams
        • 7.7.1.2.2. Gels
        • 7.7.1.2.3. Ointments
        • 7.7.1.2.4. Pastes
        • 7.7.1.2.5. Lotions
      • 7.7.1.3. Solid topical drug delivery
        • 7.7.1.3.1. Suppositories
        • 7.7.1.3.2. Powders
    • 7.7.2. DEVICES (TRANSDERMAL DRUG DELIVERY)
      • 7.7.2.1. Transdermal patches
      • 7.7.2.2. Transdermal Gels
  • 7.8. IMPLANTABLE DRUG DELIVERY
    • 7.8.1. ACTIVE IMPLANTABLE DRUG DELIVERY
    • 7.8.2. PASSIVE IMPLANTABLE DRUG DELIVERY
  • 7.9. TRANSMUCOSAL DRUG DELIVERY
    • 7.9.1. ORAL TRANSMUCOSAL DRUG DELIVERY
      • 7.9.1.1. Buccal Drug Delivery
      • 7.9.1.2. Sublingual drug delivery
    • 7.9.2. OTHER TRANSMUCOSAL DRUG DELIVERY
      • 7.9.2.1. Rectal Transmucosal Drug Delivery
      • 7.9.2.2. Vaginal Transmucosal Drug Delivery

8. DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS
  • 8.3. AMBULATORY SURGICAL CENTERS/CLINICS
  • 8.4. HOME CARE SETTINGS
  • 8.5. DIAGNOSTIC CENTERS
  • 8.6. OTHER FACILITIES OF USE

9. DRUG DELIVERY TECHNOLOGY MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. U.K.
    • 9.3.4. REST OF EUROPE (ROE)
  • 9.4. ASIA
    • 9.4.1. JAPAN
    • 9.4.2. CHINA
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATIONS & TRENDS
    • 10.3.1. PRODUCT LAUNCHES & APPROVALS
    • 10.3.2. PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 10.3.3. ACQUISITIONS, MERGERS, AND JOINT VENTURES
    • 10.3.4. EXPANSIONS

11. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 11.1. INTRODUCTION
  • 11.2. JOHNSON & JOHNSON SERVICES, INC.
  • 11.3. NOVARTIS AG
  • 11.4. F. HOFFMANN-LA ROCHE LTD.
  • 11.5. PFIZER, INC.
  • 11.6. BAYER AG
  • 11.7. ANTARES PHARMA, INC.
  • 11.8. BECTON, DICKINSON AND COMPANY
  • 11.9. GLAXOSMITHKLINE PLC
  • 11.10. 3M
  • 11.11. MERCK & CO., INC.
  • 11.12. SANOFI

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

12. APPENDIX

  • 12.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER RECENT DEVELOPMENTS
  • 12.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RT: REAL-TIME MARKET INTELLIGENCE
  • 12.7. RELATED REPORTS
  • 12.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: INDICATIVE LIST OF BIOLOGICS APPROVED BY FDA (2015 & 2016)
  • TABLE 2: MAJOR PRODUCT RECALLS IN THE DRUG DELIVERY TECHNOLOGY MARKET, 2015
  • TABLE 3: PATENT EXPIRY OF DRUGS, 2014-2015
  • TABLE 4: LIST OF REGULATORY AUTHORITIES, BY COUNTRY
  • TABLE 5: SOME OF THE RECENTLY APPROVED DRUGS BY FDA
  • TABLE 6: SOME OF THE RECENTLY APPROVED DRUGS IN EUROPE
  • TABLE 7: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 8: ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 9: ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 10: ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR SOLID DRUGS, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 11: ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR SOLID DRUGS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 12: SOLID ORAL DRUGS MARKET SIZE FOR TABLETS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 13: SOLID ORAL DRUGS MARKET SIZE FOR CAPSULES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 14: SOLID ORAL DRUGS MARKET SIZE FOR POWDERS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 15: SOLID ORAL DRUGS MARKET SIZE FOR PILLS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 16: LIQUID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 17: LIQUID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 18: LIQUID ORAL DRUGS MARKET SIZE FOR SOLUTIONS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 19: LIQUID ORAL DRUGS MARKET SIZE FOR SYRUPS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 20: SEMI-SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 21: SEMI-SOLID ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 22: SEMI-SOLID ORAL DRUGS MARKET SIZE FOR GELS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 23: SEMI-SOLID ORAL DRUGS MARKET SIZE FOR EMULSIONS, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 24: SEMI-SOLID ORAL DRUGS MARKET SIZE FOR ELIXIRS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: PULMONARY DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 26: PULMONARY DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 27: PULMONARY DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 28: PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 29: PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 30: PULMONARY DRUG DELIVERY DEVICES MARKET SIZE FOR METERED DOSE INHALERS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 31: PULMONARY DRUG DELIVERY DEVICES MARKET SIZE FOR DRY POWDER INHALERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 32: PULMONARY DRUG DELIVERY DEVICES MARKET SIZE FOR NEBULIZERS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 33: PULMONARY DRUG DELIVERY DEVICES MARKET SIZE FOR NEBULIZERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: JET NEBULIZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: ULTRASONIC NEBULIZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: SOFT MIST NEBULIZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: INJECTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 38: INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 39: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 40: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY MATERIAL, 2014-2021 (USD BILLION)
  • TABLE 41: CONVENTIONAL GLASS INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 42: CONVENTIONAL PLASTIC INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 43: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 44: CONVENTIONAL FILLABLE INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 45: CONVENTIONAL PREFILLED INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 46: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY USABILITY, 2014-2021 (USD BILLION)
  • TABLE 47: CONVENTIONAL REUSABLE INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 48: CONVENTIONAL DISPOSABLE INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 49: SELF-INJECTION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 50: SELF-INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 51: NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 52: AUTOINJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 53: COMMERCIALLY AVAILABLE KEY PEN INJECTORS
  • TABLE 54: PEN INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 55: WEARABLE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 56: OTHER INJECTOR DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 57: INJECTABLE DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 58: INJECTABLE DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 59: CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 60: CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 61: NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 62: NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 63: LONG-ACTING INJECTION FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 64: OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 65: OCULAR DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 66: OCULAR DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 67: OCULAR DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 68: LIQUID OCULAR FORMULATIONS MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 69: LIQUID OCULAR FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 70: COMMERCIALLY AVAILABLE EYE DROPS
  • TABLE 71: EYE DROPS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 72: LIQUID SPRAYS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 73: SEMI-SOLID OCULAR FORMULATIONS MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 74: SEMI-SOLID OCULAR FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 75: OCULAR GELS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 76: EYE OINTMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 77: OCULAR DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 78: OCULAR DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 79: DRUG-COATED CONTACT LENSES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 80: OCULAR INSERTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 81: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 82: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 83: NASAL DROPS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 84: NASAL SPRAYS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 85: NASAL POWDERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 86: NASAL GELS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 87: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 88: TOPICAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 89: TOPICAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 90: TOPICAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 91: LIQUID TOPICAL FORMULATIONS MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 92: LIQUID TOPICAL FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 93: TOPICAL SOLUTIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 94: TOPICAL SUSPENSIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 95: SEMI-SOLID TOPICAL FORMULATIONS MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 96: SEMI-SOLID TOPICAL FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 97: TOPICAL CREAMS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 98: TOPICAL GELS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 99: TOPICAL OINTMENTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 100: TOPICAL PASTES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 101: TOPICAL LOTIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 102: SOLID TOPICAL FORMULATIONS MARKET SIZE, BY DOSAGE FORM, 2014-2021 (USD BILLION)
  • TABLE 103: SOLID TOPICAL FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 104: TOPICAL SUPPOSITORIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 105: TOPICAL POWDERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 106: TRANSDERMAL DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 107: TRANSDERMAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 108: TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 109: TRANSDERMAL GELS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 110: IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 111: IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 112: ACTIVE IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 113: PASSIVE IMPLANTABLE DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 114: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 115: TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 116: ORAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 117: ORAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 118: BUCCAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 119: SUBLINGUAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 120: OTHER TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 121: OTHER TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 122: RECTAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 123: VAGINAL TRANSMUCOSAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 124: GLOBAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 125: GLOBAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 126: DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR HOSPITALS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 127: DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR AMBULATORY SURGICAL CENTERS/CLINICS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 128: DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR HOME CARE SETTINGS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 129: DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR DIAGNOSTIC CENTERS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 130: DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR OTHER FACILITIES OF USE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 131: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 132: NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 133: NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 134: NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 135: U.S.: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 136: U.S.: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 137: CANADA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 138: CANADA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 139: EUROPE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 140: EUROPE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 141: EUROPE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 142: GERMANY: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 143: GERMANY: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 144: FRANCE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 145: FRANCE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 146: U.K.: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 147: U.K.: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 148: ROE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 149: ROE: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 150: ASIA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 151: ASIA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 152: ASIA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 153: JAPAN: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 154: JAPAN: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 155: CHINA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 156: CHINA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 157: INDIA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 158: INDIA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 159: ROA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 160: ROA: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014-2021 (USD BILLION)
  • TABLE 161: ROW: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 162: ROW: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 163: PRODUCT LAUNCHES & APPROVALS, 2014-2016
  • TABLE 164: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2014-2016
  • TABLE 165: ACQUISITIONS, MERGERS, AND JOINT VENTURES, 2014-2016
  • TABLE 166: EXPANSIONS, 2014-2016
  • TABLE 167: EXCHANGE RATES (UTILIZED FOR CONVERSION OF CHF TO USD)
  • TABLE 168: EXCHANGE RATE (UTILIZED FOR CONVERSION OF EUR TO USD)
  • TABLE 169: EXCHANGE RATE (UTILIZED FOR CONVERSION OF GBP TO USD)
  • TABLE 170: EXCHANGE RATE (UTILIZED FOR CONVERSION OF EUR TO USD)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 1: DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION (2016)
  • FIGURE 2: ORAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR SOLID DRUGS, BY DOSAGE FORM, 2016 VS. 2021 (USD BILLION)
  • FIGURE 3: DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY FACILITY OF USE, 2016 VS. 2021 (USD BILLION)
  • FIGURE 4: DRUG DELIVERY TECHNOLOGY MARKET, BY REGION,
  • FIGURE 5 : ASE OF USE, RISING PREVALENCE OF CHRONIC DISEASES ARE DRIVING MARKET GROWTH
  • FIGURE 6 : OSPITALS SEGMENT TO HOLD LARGEST MARKET SHARE FROM 2016 TO 2021
  • FIGURE 7 : ABLETS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2016
  • FIGURE 8 : RAL DRUG DELIVERY TO HOLD LARGEST SHARE IN THE MARKET IN 2016
  • FIGURE 9 : HINA TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 10: DRUG DELIVERY TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 11: TOPICAL DRUG DELIVERY TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 12: THE HOSPITALS SEGMENT IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE DRUG DELIVERY TECHNOLOGY MARKET IN 2016
  • FIGURE 13: NORTH AMERICA: DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 14: EUROPE: DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 15: ASIA: DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 16: ROW: DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 17: PRODUCT LAUNCHES & APPROVALS: KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE DRUG DELIVERY TECHNOLOGY MARKET (2014-2016)
  • FIGURE 18: GLOBAL DRUG DELIVERY TECHNOLOGY MARKET SHARE, BY KEY PLAYER (2015)
  • FIGURE 19: MARKET EVOLUTION FRAMEWORK: PRODUCT LAUNCHES & APPROVALS ARE FUELING MARKET GROWTH
  • FIGURE 20: BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES & APPROVALS IS THE KEY GROWTH STRATEGY ADOPTED BY LEADING MARKET PLAYERS
  • FIGURE 21: GEOGRAPHIC REVENUE MIX FOR THE TOP 5 PLAYERS
  • FIGURE 22: JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 23: NOVARTIS AG: COMPANY SNAPSHOT (2015)
  • FIGURE 24: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2015)
  • FIGURE 25: PFIZER, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 26: BAYER AG: COMPANY SNAPSHOT (2015)
  • FIGURE 27: ANTARES PHARMA, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 28: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2015)
  • FIGURE 29: GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT (2015)
  • FIGURE 30: 3M: COMPANY SNAPSHOT (2015)
  • FIGURE 31: MERCK & CO., INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 32: SANOFI: COMPANY SNAPSHOT (2015)
Back to Top